Alzheimer's disease - International conferenceInternational Conference

alz97 at server3.medizin.uni-leipzig.de alz97 at server3.medizin.uni-leipzig.de
Fri Feb 28 05:16:46 EST 1997


International Conference
Alzheimer’s Disease - From Basic Research to Clinical Applications
Leipzig / Germany , June 4 - 7 1997
Neues Gewandhaus

e-mail: alz97 at server3.medizin.uni-leipzig.de
http://www.uni-leipzig.de/medizin/alz97

			Preliminary Program

Wednesday, June 4
19.00 - 21.00		Opening ceremony, Honory lecture
			Sir Martin Roth, Cambridge

Thursday, June 5
9.00 - 12.00		Longitudinal Studies / Progression of the Disease
			L. Gustafson, Kopenhagen
			Clinical Manifestations and heterogeneity of AD
			K.Jobst, Oxford
			The course of AD
			B. Reisberg, New York
			Variability of progression in AD
			B. Winblad, Stockholm
			Mild cognitive decline - an early stage of AD?
			H.-J. Gertz, Leipzig
			Mild cognitve decline and its implications for therapeutic
interventions
			I.G. McKeith, Newcastle
			What are the relations between Lewy body disease and AD?
			Ph. Scheltens, Amsterdam
			The influence of coincidental vascular pathology on symptomatology 
and course of AD
13.45 - 14.55		poster presentations / oral presentation of selected
posters
15.00 - 18.00		Pathogenetic theories and therapeutic approaches (part I)
		free radicals:		P. Riederer, Wuerzburg;		M. Roesler, Wuerzburg
		calcium metabolism:	W.E. Mueller, Mannheim;		R. Ihl, Duesseldorf
		glucose metabolism:	S. Hoyer, Heidelberg;		S. Kanowski, Berlin
19.00			Concert, St Thomas` Church, afterwards Gala Dinner Auerbachs
Keller

Friday, June 6
8.30 - 12.00		Symposium - Significance of tau and amyloid pathology
			K. Jellinger, Vienna
			Introduction
			V.M.-Y. Lee, Pennsylvania
			Pathology of tau
			R. Nitsch, Hamburg
			APP and formation of ßA4
			C.M. Wischik, Cambridge
			Therapeutic strategies deriving from tau-pathology
			Th. Arendt, Leipzig
			Alterations in signal transduction
11.00 - 12.00 		Round table discussions:
			Consequences of tau and amyloid research for therapeutic strategies
13.45 - 14.55		oral presentation of selected posters
15.00 - 18.00		Pathogenetic theories and therapeutic approaches (part
II)
	Immunpathology		P. Schubert, Muenchen;		H.-J. Moeller, Muenchen		
	cholinergic deficit	V. Bigl, Leipzig;		A. Kurz, Muenchen
	glutamergic system	J. Kornhuber, Goettingen	C.G. Gottfries, Goeteburg

Saturday, June 7
9.00 - 12.00		Symposium - Risk factors and Prevention
			Ch. Haas, Mannheim
			Genetics of AD
			J. Poirier, Montreal
			Apo E as a risk factor and predictor of therapeutic efficacy
			A.J. Holland, Cambridge
			Is Down ‘s Syndrome a suitable modell of AD?
			H. Braak, Frankfurt/M
			Senile Dementia - an early onset disease?
			P. McGeer, Vancouver
			The role of antiininflammatory agents in the treatment of AD
12.00 - 13.00		Round table discussions:
			The problem of aetiological heterogeneity and its relevance for 
			preventive and therapeutic strategies

Organizing Societies:
University of Leipzig, Clinic of Psychiatry, Paul Flechsig Institute for
Brain Research and Interdisciplinary Centre for Clinical Research 
Leipzig
together with:
Arbeitsgemeinschaft fuer Neuropsychopharmakologie und
Pharmakopsychiatrie (AGNP)
Deutsche Gesellschaft fuer Biologische Psychiatry (DGBP)
Hirnliga e.V.
Deutsche Alzheimer Gesellschaft e.V.
Alzheimer Gesellschaft Leipzig e.V.

Organizers:
Hermann-Josef Gertz
Thomas Arendt

Secretariat:
University of Leipzig, Clinic for Psychiatry
Emilienstr. 14
04107 Leipzig / Germany
phone: 	+49 341 9724500
fax		+49 341 9724509
e-mail:		alz97 at server3.medizin.uni-leipzig.de
www:		http://www.uni-leipzig.de/medizin/alz97



More information about the Neur-sci mailing list